Latest & greatest articles for autism

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on autism or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on autism and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Autism

Autism is a neurodevelopmental disorder (a type of mental disorder) characterised by difficult social interaction, impaired communication (both verbal and non-verbal), and restricted and repetitive behaviours. It forms part of the broader autism spectrum disorder (ASD), a range of similar conditions, including Asperger syndrome.

Autism is a condition that begins from early childhood and is often suspected and diagnosed by ages 1-3. It is a lifelong disability that affects how people interact with others.

Autism causes and treatment

There have been many misconceptions as to what causes autism in the past such as the MMR vaccine and diet. Extensive research and clinical trials have concluded that none of these factors cause autism or ASD. However, the real cause is little understood but research is starting to unpick potential factors such as genetics, pollution and other environmental factors. A current favoured idea is that genes inherited from a child’s parents can make them more vulnerable to developing autism, some researchers suggest that the disorder will only develop when triggered by environmental factors.

The exact cause of autism spectrum disorder is unknown, however research into the disorder suggest that it is caused by several genetic and environmental factors. Genes inherited from a child’s parents can make them more vulnerable to developing autism, some researchers suggest that the disorder will only develop when triggered by environmental factors. Read more in clinical papers on autism.

Autism can be managed with a combination of prescribed medicines and behavioural treatment, depending on the severity of the disorder. Read about clinical trials and medical advancements for the treatment of autism on Trip.

Hot topics in Trip

Users of Trip frequently look at topics around adolescents, therapies, behaviour and screening. They also explore such topics as omega-3 fatty acids, SSRIs and aripiprazole. All these topics, and more, can be easily searched for within Trip.

Top results for autism

1. Psychotropic drugs and people with learning disabilities or autism

Psychotropic drugs and people with learning disabilities or autism Psychotropic drugs and people with learning disabilities or autism: executive summary - GOV.UK GOV.UK uses cookies to make the site simpler. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance Psychotropic drugs and people with learning disabilities or autism: executive summary Published 22 March 2019 Contents © Crown copyright 2019 This publication is licensed under the terms of the Open (...) Government Licence v3.0 except where otherwise stated. To view this licence, visit or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: . Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned. This publication is available at https://www.gov.uk/government/publications/psychotropic-drugs-and-people-with-learning-disabilities-or-autism/psychotropic-drugs-and-people-with-learning

2019 Public Health England

2. Measles, Mumps, Rubella Vaccination and Autism: A Nationwide Cohort Study. (PubMed)

Measles, Mumps, Rubella Vaccination and Autism: A Nationwide Cohort Study. The hypothesized link between the measles, mumps, rubella (MMR) vaccine and autism continues to cause concern and challenge vaccine uptake.To evaluate whether the MMR vaccine increases the risk for autism in children, subgroups of children, or time periods after vaccination.Nationwide cohort study.Denmark.657 461 children born in Denmark from 1999 through 31 December 2010, with follow-up from 1 year of age and through 31 (...) August 2013.Danish population registries were used to link information on MMR vaccination, autism diagnoses, other childhood vaccines, sibling history of autism, and autism risk factors to children in the cohort. Survival analysis of the time to autism diagnosis with Cox proportional hazards regression was used to estimate hazard ratios of autism according to MMR vaccination status, with adjustment for age, birth year, sex, other childhood vaccines, sibling history of autism, and autism risk factors

Full Text available with Trip Pro

2019 Annals of Internal Medicine

3. Parent-focused therapy has some long-term benefits for children with autism

Parent-focused therapy has some long-term benefits for children with autism Parent-focused therapy has some long-term benefits for children with autism Discover Portal Discover Portal Parent-focused therapy has some long-term benefits for children with autism Published on 14 February 2017 doi: A parent-focused therapy for young children with autism continues to have beneficial effects on symptoms and communication almost six years after the end of treatment. This UK randomised controlled trial (...) investigated the effects of a one-year social communication therapy in 152 UK children aged two to four years with severe autism. The therapy, partly delivered by parents, aimed to help them adapt their style of interacting with their child. Children who received the intervention had less severe symptoms at the end of the initial one-year intervention period than those who received treatment as usual. When these children were followed up nearly six years later at age seven to 11 years, children who had

2019 NIHR Dissemination Centre

4. Behaviour related outcome assessments for children with autism and co-occurring intellectual disabilities appropriate for use in educational settings: a systematic review

Behaviour related outcome assessments for children with autism and co-occurring intellectual disabilities appropriate for use in educational settings: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2019 PROSPERO

5. Blood-based proteomic and metabolomic biomarkers for Autism Spectrum Disorder and Attention-Deficit Hyperactivity Disorder: a systematic review

Blood-based proteomic and metabolomic biomarkers for Autism Spectrum Disorder and Attention-Deficit Hyperactivity Disorder: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

6. The experience of online learning for tertiary students on the autism spectrum

The experience of online learning for tertiary students on the autism spectrum Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2019 PROSPERO

7. The relationship between the intolerance of uncertainty and anxiety in people with autism spectrum disorder: a systematic review and meta analysis

The relationship between the intolerance of uncertainty and anxiety in people with autism spectrum disorder: a systematic review and meta analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

8. The effectiveness of aquatic therapy on behaviors of children with autism: a systematic review

The effectiveness of aquatic therapy on behaviors of children with autism: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2019 PROSPERO

9. The effectiveness and safety of oxytocin in treating Autism Spectrum Disorder-relevant behaviors in animals

The effectiveness and safety of oxytocin in treating Autism Spectrum Disorder-relevant behaviors in animals Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

10. The effectiveness and safety of oxytocin in treating Autism Spectrum Disorder

The effectiveness and safety of oxytocin in treating Autism Spectrum Disorder Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2019 PROSPERO

11. The effectiveness and safety of methylcobalamin in treating Autism Spectrum Disorder-relevant behaviors in animals

The effectiveness and safety of methylcobalamin in treating Autism Spectrum Disorder-relevant behaviors in animals Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated

2019 PROSPERO

12. The effectiveness and safety of methylcobalamin in treating Autism Spectrum Disorder

The effectiveness and safety of methylcobalamin in treating Autism Spectrum Disorder Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites

2019 PROSPERO

13. The effectiveness and safety of melatoninin treating Autism Spectrum Disorder-relevant behaviors in animals

The effectiveness and safety of melatoninin treating Autism Spectrum Disorder-relevant behaviors in animals Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

14. The effectiveness and safety of melatonin in treating Autism Spectrum Disorder

The effectiveness and safety of melatonin in treating Autism Spectrum Disorder Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2019 PROSPERO

15. The effectiveness and safety of inositol in treating Autism Spectrum Disorder-relevant behaviors in animals

The effectiveness and safety of inositol in treating Autism Spectrum Disorder-relevant behaviors in animals Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

16. The effectiveness and safety of glutathione in treating Autism Spectrum Disorder-relevant behaviors in animals

The effectiveness and safety of glutathione in treating Autism Spectrum Disorder-relevant behaviors in animals Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

17. The effectiveness and safety of glutathione in treating Autism Spectrum Disorder

The effectiveness and safety of glutathione in treating Autism Spectrum Disorder Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2019 PROSPERO

18. The effectiveness and safety of 2, 3-dimercapto-1-propanesulfonic acid sodium (DMPS) in treating Autism Spectrum Disorder-relevant behaviors in animals

The effectiveness and safety of 2, 3-dimercapto-1-propanesulfonic acid sodium (DMPS) in treating Autism Spectrum Disorder-relevant behaviors in animals Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

19. The effectiveness and safety of 2, 3-dimercapto-1-propanesulfonic acid sodium (DMPS) in treating Autism Spectrum Disorder

The effectiveness and safety of 2, 3-dimercapto-1-propanesulfonic acid sodium (DMPS) in treating Autism Spectrum Disorder Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

20. The prevalence of autism spectrum disorder in India: a meta-analysis

The prevalence of autism spectrum disorder in India: a meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation

2019 PROSPERO